In gastric cancer, the interaction of PHGDH with insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) stabilizes TCF7L2 mRNA and increases its expression, resulting in the activation of the Wnt/β-catenin signaling pathway thereby contributing to multi-drug resistance [13]. The gene discussed is IGF2BP1; the disease is gastric cancer.